Prairie Wealth Advisors Inc. Lowers Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Prairie Wealth Advisors Inc. reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 37.6% in the fourth quarter, Holdings Channel reports. The firm owned 4,223 shares of the exchange traded fund’s stock after selling 2,550 shares during the period. Prairie Wealth Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $380,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Avior Wealth Management LLC increased its stake in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares during the last quarter. Tidemark LLC grew its holdings in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $44,000. Finally, Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF during the third quarter valued at approximately $49,000.

SPDR S&P Biotech ETF Stock Down 1.4 %

XBI opened at $93.37 on Friday. The business’s fifty day simple moving average is $92.75 and its 200 day simple moving average is $96.55. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The stock has a market cap of $7.12 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.